You're contacting media contact of this press release

Title: CoreAge Rx Introduces Sermorelin Therapy to Expand Anti-Aging Treatment Options

Wichita -  Falls, TX, United States, 23rd Apr 2026CoreAge Rx today announced the launch of Sermorelin therapy as part of its anti-aging treatment offerings, providing patients with a physician-guided option designed to support natural human growth hormone (HGH) production through its telehealth platform.Sermorelin, when available, is now accessible to eligible patients following an online evaluation and physician approval. The therapy is offered through CoreAge Rx’s digital model, allowing individuals to complete the process from consultation to medication delivery without in-person visits.Understanding Sermorelin TherapyAccording to CoreAge Rx, Sermorelin is a growth hormone-releasing hormone (GHRH) that works by stimulating the body’s natural production of human growth hormone. It acts on the hypothalamus to release GHRH, which then signals the pituitary gland to produce HGH. This process subsequently increases insulin-like growth factor 1 (IGF-1), which is associated with fat breakdown and bone strength.The company notes that because Sermorelin stimulates the body’s own production of HGH, it is positioned as an alternative approach compared to therapies that introduce synthetic HGH.Reported Benefits of SermorelinCoreAge Rx states that Sermorelin therapy is associated with several potential benefits related to increased human growth hormone levels.These include:Increased natural production of human growth hormoneImproved sleep quality, as HGH is released during deep sleepSupport for muscle growth and repairFat breakdown and weight management supportImprovements in skin elasticity and hair healthIncreased energy levelsThe company indicates that some individuals may begin to notice certain effects within days to weeks, while other changes may take several months de...

This press release is issued by King Newswire